Truist Securities Reiterates Buy on Guardian Pharmacy Service, Raises Price Target to $28
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
Truist Securities analyst David Macdonald reiterates Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $25 to $28.
Truist Securities analyst David Macdonald reiterates Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $25 to $28.